Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 2 1Phase 1 1

Status

Completed 2Terminated 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 16Head & Neck 7Genitourinary 4Lymphoid 3Endocrine 3Other hematologic neoplasm 2Thoracic 1Plasma cell 1Other 1Myeloid 1Dermatologic 1Classical hematology 1CNS 1Breast 1

Conditions

Multiple Endocrine Neoplasia Type 1 2Thyroid Cancer, Papillary 1Sexual Behavior 1Homosexuality 1Depression 1Alcoholism 1Alcohol Drinking 1

Interventions

lutetium Lu 177 dotatate 36Everolimus 32pembrolizumab 24Temozolomide 21Magnetic Resonance Spectroscopy 21Nivolumab 18lenvatinib 17gallium Ga 68 dotatate 16cabozantinib 15Cisplatin 15lanreotide 143-Iodobenzylguanidine 14Capecitabine 13trametinib 12dabrafenib 12Bevacizumab 12Octreotide 11Surveys and Questionnaires 10Surgical Procedures, Operative 10Sunitinib 10Radiosurgery 10Positron Emission Tomography Computed Tomography 10Blood Specimen Collection 10Sorafenib 9Paclitaxel 9Ipilimumab 9Carboplatin 9surufatinib 8Etoposide 8Doxorubicin 8

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
OTHER × Ethanol × Endocrine × Clear all
NCT03361384 2021-07-23

Alcohol and Implicit Process in Sexual Risk Behavior in MSM

Syracuse University

Phase 1 Completed
260 enrolled
Endocrine

Alcohol Drinking, Homosexuality, Sexual Behavior, Multiple Endocrine Neoplasia Type 1

NCT01974284 2019-11-25

Percutaneous Ethanol Injection for Primary Papillary Thyroid Microcarcinoma

Yale University

Phase NA Terminated
7 enrolled 4 charts
EndocrineHead & Neck

Thyroid Cancer, Papillary

NCT00851669 2013-07-16

MEADOW/Bridge

University of Rochester

Phase 2 Completed
91 enrolled
Endocrine

Alcoholism, Depression, Multiple Endocrine Neoplasia Type 1

Data powered by HemOnc (CC BY 4.0) Colophon âš¡